nodes	percent_of_prediction	percent_of_DWPC	metapath
Gamma Hydroxybutyric Acid—SLC52A2—prostate gland—prostate cancer	0.0201	0.112	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—seminal vesicle—prostate cancer	0.017	0.0948	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—urethra—prostate cancer	0.0135	0.075	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—prostate gland—prostate cancer	0.012	0.0668	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—prostate gland—prostate cancer	0.0115	0.0638	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—bone marrow—prostate cancer	0.0104	0.0577	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—testis—prostate cancer	0.00887	0.0494	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—epithelium—prostate cancer	0.00882	0.0491	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—renal system—prostate cancer	0.00818	0.0455	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—urethra—prostate cancer	0.00803	0.0447	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—urethra—prostate cancer	0.00767	0.0427	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—prostate gland—prostate cancer	0.00729	0.0406	CbGeAlD
Gamma Hydroxybutyric Acid—SLC52A2—lymph node—prostate cancer	0.00643	0.0358	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—bone marrow—prostate cancer	0.00618	0.0344	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—epithelium—prostate cancer	0.00536	0.0298	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—testis—prostate cancer	0.00529	0.0294	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—testis—prostate cancer	0.00504	0.0281	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—renal system—prostate cancer	0.00497	0.0277	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—lymph node—prostate cancer	0.00383	0.0213	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A7—lymph node—prostate cancer	0.00366	0.0204	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—testis—prostate cancer	0.00321	0.0179	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A1—lymph node—prostate cancer	0.00233	0.013	CbGeAlD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000217	0.00116	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000216	0.00115	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CBR1—prostate cancer	0.000216	0.00115	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ADI1—prostate cancer	0.000216	0.00115	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TST—prostate cancer	0.000216	0.00115	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CSAD—prostate cancer	0.000216	0.00115	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GRHL1—prostate cancer	0.000216	0.00115	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PSAT1—prostate cancer	0.000216	0.00115	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTA3—prostate cancer	0.000213	0.00114	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—TCN2—prostate cancer	0.000213	0.00114	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PDHA1—prostate cancer	0.000213	0.00114	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—UCP3—prostate cancer	0.000213	0.00114	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—GNG5—prostate cancer	0.00021	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—PPARA—prostate cancer	0.00021	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—ITGB3—prostate cancer	0.000209	0.00112	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HSD3B1—prostate cancer	0.000203	0.00108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC22A3—prostate cancer	0.000203	0.00108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000202	0.00108	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—SRC—prostate cancer	0.0002	0.00107	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—UGT2B17—prostate cancer	0.0002	0.00107	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GRHPR—prostate cancer	0.0002	0.00107	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CKMT2—prostate cancer	0.0002	0.00107	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—UGT2B15—prostate cancer	0.0002	0.00107	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTA4—prostate cancer	0.000195	0.00104	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—TBXAS1—prostate cancer	0.000195	0.00104	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000191	0.00102	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTA2—prostate cancer	0.00019	0.00101	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NAGLU—prostate cancer	0.000188	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SULT2B1—prostate cancer	0.000188	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PGAM2—prostate cancer	0.000188	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—RFK—prostate cancer	0.000188	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTM3—prostate cancer	0.000188	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MBTPS1—prostate cancer	0.000188	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—AOX1—prostate cancer	0.000188	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ABCG5—prostate cancer	0.000188	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SULT1A1—prostate cancer	0.000188	0.001	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000187	0.000995	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PLAU—prostate cancer	0.000184	0.000982	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTA1—prostate cancer	0.000183	0.000977	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000182	0.000969	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NAT2—prostate cancer	0.000181	0.000966	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTO1—prostate cancer	0.000181	0.000966	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HSD3B2—prostate cancer	0.000181	0.000966	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—COMT—prostate cancer	0.000181	0.000965	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CAV1—prostate cancer	0.00018	0.00096	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PRKACB—prostate cancer	0.000179	0.000954	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP3A43—prostate cancer	0.000179	0.000952	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—AMACR—prostate cancer	0.000179	0.000952	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NAT1—prostate cancer	0.000179	0.000952	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—DEGS1—prostate cancer	0.000179	0.000952	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SRD5A2—prostate cancer	0.000179	0.000952	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—THBS1—prostate cancer	0.000175	0.00093	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PLCB2—prostate cancer	0.000174	0.000926	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—LRP2—prostate cancer	0.000174	0.000926	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP2C18—prostate cancer	0.000174	0.000926	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HSD17B1—prostate cancer	0.00017	0.000908	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—P4HB—prostate cancer	0.00017	0.000908	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PRKCZ—prostate cancer	0.000169	0.0009	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000168	0.000896	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A7—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000166	0.000887	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—KRAS—prostate cancer	0.000166	0.000885	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC22A1—prostate cancer	0.000166	0.000884	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—PPARA—prostate cancer	0.000166	0.000883	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000165	0.000879	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CG—prostate cancer	0.000164	0.000874	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—EGF—prostate cancer	0.000162	0.000864	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SULT2A1—prostate cancer	0.000162	0.000861	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MED12—prostate cancer	0.000159	0.000847	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GNG5—prostate cancer	0.000158	0.000841	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000157	0.000836	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000155	0.000826	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—prostate cancer	0.000152	0.000813	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—CREBBP—prostate cancer	0.000152	0.00081	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Agitation—Prednisone—prostate cancer	0.000152	0.00024	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—B4GALT4—prostate cancer	0.000152	0.00081	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NCOA3—prostate cancer	0.000152	0.00081	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HPGD—prostate cancer	0.000152	0.00081	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema—Capecitabine—prostate cancer	0.000151	0.000239	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Capecitabine—prostate cancer	0.00015	0.000238	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IGF1—prostate cancer	0.00015	0.0008	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urticaria—Etoposide—prostate cancer	0.00015	0.000236	CcSEcCtD
Gamma Hydroxybutyric Acid—Stomatitis—Doxorubicin—prostate cancer	0.000149	0.000236	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Docetaxel—prostate cancer	0.000149	0.000236	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Capecitabine—prostate cancer	0.000149	0.000235	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Epirubicin—prostate cancer	0.000149	0.000235	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Etoposide—prostate cancer	0.000149	0.000235	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Capecitabine—prostate cancer	0.000149	0.000235	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Prednisone—prostate cancer	0.000149	0.000235	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Prednisone—prostate cancer	0.000148	0.000234	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Epirubicin—prostate cancer	0.000148	0.000234	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Epirubicin—prostate cancer	0.000147	0.000233	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Capecitabine—prostate cancer	0.000147	0.000232	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Epirubicin—prostate cancer	0.000147	0.000232	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Capecitabine—prostate cancer	0.000146	0.000231	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Epirubicin—prostate cancer	0.000146	0.000231	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000146	0.000779	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Haematuria—Doxorubicin—prostate cancer	0.000146	0.000231	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Epirubicin—prostate cancer	0.000146	0.000231	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Epirubicin—prostate cancer	0.000146	0.00023	CcSEcCtD
Gamma Hydroxybutyric Acid—Loss of consciousness—Prednisone—prostate cancer	0.000145	0.00023	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—HPGDS—prostate cancer	0.000145	0.000772	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Epistaxis—Doxorubicin—prostate cancer	0.000144	0.000228	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Capecitabine—prostate cancer	0.000144	0.000228	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Estradiol—prostate cancer	0.000144	0.000228	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CD—prostate cancer	0.000144	0.000768	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP2C19—prostate cancer	0.000144	0.000768	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Mitoxantrone—prostate cancer	0.000144	0.000227	CcSEcCtD
Gamma Hydroxybutyric Acid—Sinusitis—Doxorubicin—prostate cancer	0.000144	0.000227	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PRKCQ—prostate cancer	0.000144	0.000765	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Convulsion—Prednisone—prostate cancer	0.000143	0.000226	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TNFRSF21—prostate cancer	0.000143	0.000761	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypertension—Prednisone—prostate cancer	0.000143	0.000226	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Mitoxantrone—prostate cancer	0.000143	0.000225	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Mitoxantrone—prostate cancer	0.000143	0.000225	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—SERPINE1—prostate cancer	0.000143	0.00076	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000143	0.000225	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PLAUR—prostate cancer	0.000142	0.000756	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Mitoxantrone—prostate cancer	0.000142	0.000224	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Docetaxel—prostate cancer	0.000141	0.000224	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Prednisone—prostate cancer	0.000141	0.000222	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Prednisone—prostate cancer	0.000141	0.000222	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ACHE—prostate cancer	0.000141	0.000749	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTT1—prostate cancer	0.000141	0.000749	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Docetaxel—prostate cancer	0.00014	0.000222	CcSEcCtD
Gamma Hydroxybutyric Acid—Anxiety—Prednisone—prostate cancer	0.00014	0.000222	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.00014	0.000221	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Docetaxel—prostate cancer	0.000139	0.00022	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000139	0.000743	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Somnolence—Docetaxel—prostate cancer	0.000139	0.00022	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP7B1—prostate cancer	0.000139	0.000741	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MTAP—prostate cancer	0.000139	0.000741	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP2A6—prostate cancer	0.000139	0.000741	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Eye disorder—Epirubicin—prostate cancer	0.000139	0.000219	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Etoposide—prostate cancer	0.000139	0.000219	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Epirubicin—prostate cancer	0.000138	0.000219	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000138	0.000218	CcSEcCtD
Gamma Hydroxybutyric Acid—Cardiac disorder—Epirubicin—prostate cancer	0.000138	0.000218	CcSEcCtD
Gamma Hydroxybutyric Acid—Rhinitis—Doxorubicin—prostate cancer	0.000138	0.000218	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Docetaxel—prostate cancer	0.000138	0.000218	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Capecitabine—prostate cancer	0.000137	0.000216	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypoaesthesia—Doxorubicin—prostate cancer	0.000137	0.000216	CcSEcCtD
Gamma Hydroxybutyric Acid—Pharyngitis—Doxorubicin—prostate cancer	0.000136	0.000216	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—NOS3—prostate cancer	0.000136	0.000726	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Capecitabine—prostate cancer	0.000136	0.000215	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Docetaxel—prostate cancer	0.000136	0.000215	CcSEcCtD
Gamma Hydroxybutyric Acid—Urinary tract disorder—Doxorubicin—prostate cancer	0.000136	0.000214	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema peripheral—Doxorubicin—prostate cancer	0.000135	0.000214	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SULT1E1—prostate cancer	0.000135	0.000722	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SRD5A1—prostate cancer	0.000135	0.000722	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—AKR1C3—prostate cancer	0.000135	0.00072	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000135	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Etoposide—prostate cancer	0.000135	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Connective tissue disorder—Doxorubicin—prostate cancer	0.000135	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Capecitabine—prostate cancer	0.000135	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Prednisone—prostate cancer	0.000135	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Docetaxel—prostate cancer	0.000135	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Epirubicin—prostate cancer	0.000135	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Urethral disorder—Doxorubicin—prostate cancer	0.000135	0.000213	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Mitoxantrone—prostate cancer	0.000134	0.000212	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PRKACB—prostate cancer	0.000134	0.000717	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Immune system disorder—Epirubicin—prostate cancer	0.000134	0.000212	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Prednisone—prostate cancer	0.000134	0.000212	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Epirubicin—prostate cancer	0.000134	0.000212	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Docetaxel—prostate cancer	0.000134	0.000211	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Docetaxel—prostate cancer	0.000134	0.000211	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000134	0.000713	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspepsia—Capecitabine—prostate cancer	0.000133	0.000211	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Epirubicin—prostate cancer	0.000133	0.000211	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP17A1—prostate cancer	0.000133	0.000709	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Shock—Prednisone—prostate cancer	0.000133	0.00021	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervous system disorder—Prednisone—prostate cancer	0.000132	0.000209	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—JAK2—prostate cancer	0.000132	0.000705	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Capecitabine—prostate cancer	0.000132	0.000208	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—VAV3—prostate cancer	0.000132	0.000702	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.000132	0.000701	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Alopecia—Epirubicin—prostate cancer	0.000131	0.000207	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Prednisone—prostate cancer	0.000131	0.000207	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000131	0.000207	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Capecitabine—prostate cancer	0.000131	0.000206	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Prednisone—prostate cancer	0.00013	0.000206	CcSEcCtD
Gamma Hydroxybutyric Acid—Mental disorder—Epirubicin—prostate cancer	0.00013	0.000206	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Capecitabine—prostate cancer	0.00013	0.000205	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Capecitabine—prostate cancer	0.00013	0.000205	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Epirubicin—prostate cancer	0.000129	0.000204	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HSD17B3—prostate cancer	0.000129	0.000689	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ACSL4—prostate cancer	0.000129	0.000689	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Docetaxel—prostate cancer	0.000129	0.000204	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Etoposide—prostate cancer	0.000129	0.000204	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Prednisone—prostate cancer	0.000129	0.000203	CcSEcCtD
Gamma Hydroxybutyric Acid—Eye disorder—Doxorubicin—prostate cancer	0.000128	0.000203	CcSEcCtD
Gamma Hydroxybutyric Acid—Tinnitus—Doxorubicin—prostate cancer	0.000128	0.000202	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Docetaxel—prostate cancer	0.000128	0.000202	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ITPR1—prostate cancer	0.000128	0.000681	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Cardiac disorder—Doxorubicin—prostate cancer	0.000128	0.000202	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Epirubicin—prostate cancer	0.000127	0.0002	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NCOA2—prostate cancer	0.000127	0.000676	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dysgeusia—Epirubicin—prostate cancer	0.000127	0.0002	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000126	0.000674	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000126	0.000672	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CB—prostate cancer	0.000126	0.00067	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervousness—Epirubicin—prostate cancer	0.000126	0.000198	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Epirubicin—prostate cancer	0.000125	0.000198	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Capecitabine—prostate cancer	0.000125	0.000197	CcSEcCtD
Gamma Hydroxybutyric Acid—Angiopathy—Doxorubicin—prostate cancer	0.000125	0.000197	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Etoposide—prostate cancer	0.000124	0.000197	CcSEcCtD
Gamma Hydroxybutyric Acid—Muscle spasms—Epirubicin—prostate cancer	0.000124	0.000196	CcSEcCtD
Gamma Hydroxybutyric Acid—Immune system disorder—Doxorubicin—prostate cancer	0.000124	0.000196	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Capecitabine—prostate cancer	0.000124	0.000196	CcSEcCtD
Gamma Hydroxybutyric Acid—Mediastinal disorder—Doxorubicin—prostate cancer	0.000124	0.000196	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PHGDH—prostate cancer	0.000124	0.00066	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ARG2—prostate cancer	0.000124	0.00066	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—UMPS—prostate cancer	0.000124	0.00066	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Docetaxel—prostate cancer	0.000124	0.000195	CcSEcCtD
Gamma Hydroxybutyric Acid—Chills—Doxorubicin—prostate cancer	0.000123	0.000195	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000123	0.000657	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000123	0.000194	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Prednisone—prostate cancer	0.000122	0.000193	CcSEcCtD
Gamma Hydroxybutyric Acid—Vision blurred—Epirubicin—prostate cancer	0.000122	0.000193	CcSEcCtD
Gamma Hydroxybutyric Acid—Alopecia—Doxorubicin—prostate cancer	0.000121	0.000192	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—LDHB—prostate cancer	0.000121	0.000647	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Prednisone—prostate cancer	0.000121	0.000191	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—SLC5A5—prostate cancer	0.000121	0.000645	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Mental disorder—Doxorubicin—prostate cancer	0.00012	0.00019	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Capecitabine—prostate cancer	0.00012	0.00019	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.00012	0.000641	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Capecitabine—prostate cancer	0.00012	0.000189	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Etoposide—prostate cancer	0.00012	0.000189	CcSEcCtD
Gamma Hydroxybutyric Acid—Malnutrition—Doxorubicin—prostate cancer	0.00012	0.000189	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Epirubicin—prostate cancer	0.000119	0.000189	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP3A5—prostate cancer	0.000119	0.000635	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Agitation—Epirubicin—prostate cancer	0.000119	0.000188	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Prednisone—prostate cancer	0.000119	0.000188	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Etoposide—prostate cancer	0.000119	0.000188	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Etoposide—prostate cancer	0.000119	0.000187	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP2E1—prostate cancer	0.000118	0.00063	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Etoposide—prostate cancer	0.000118	0.000186	CcSEcCtD
Gamma Hydroxybutyric Acid—Tension—Doxorubicin—prostate cancer	0.000117	0.000185	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Prednisone—prostate cancer	0.000117	0.000185	CcSEcCtD
Gamma Hydroxybutyric Acid—Dysgeusia—Doxorubicin—prostate cancer	0.000117	0.000185	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000117	0.000625	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NQO1—prostate cancer	0.000117	0.000623	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Fatigue—Prednisone—prostate cancer	0.000116	0.000184	CcSEcCtD
Gamma Hydroxybutyric Acid—Nervousness—Doxorubicin—prostate cancer	0.000116	0.000184	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Epirubicin—prostate cancer	0.000116	0.000184	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Epirubicin—prostate cancer	0.000116	0.000183	CcSEcCtD
Gamma Hydroxybutyric Acid—Back pain—Doxorubicin—prostate cancer	0.000116	0.000183	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Prednisone—prostate cancer	0.000115	0.000182	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—IL2—prostate cancer	0.000115	0.000615	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Docetaxel—prostate cancer	0.000115	0.000182	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PDHA1—prostate cancer	0.000115	0.000614	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—UCP3—prostate cancer	0.000115	0.000614	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA3—prostate cancer	0.000115	0.000614	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—TH—prostate cancer	0.000115	0.000614	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TCN2—prostate cancer	0.000115	0.000614	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Muscle spasms—Doxorubicin—prostate cancer	0.000115	0.000182	CcSEcCtD
Gamma Hydroxybutyric Acid—Palpitations—Epirubicin—prostate cancer	0.000114	0.000181	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP3A4—prostate cancer	0.000114	0.000607	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Loss of consciousness—Epirubicin—prostate cancer	0.000114	0.00018	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—ITGB3—prostate cancer	0.000113	0.000603	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vision blurred—Doxorubicin—prostate cancer	0.000113	0.000178	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Docetaxel—prostate cancer	0.000112	0.000177	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Epirubicin—prostate cancer	0.000112	0.000177	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP1B1—prostate cancer	0.000112	0.000597	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Etoposide—prostate cancer	0.000112	0.000177	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Epirubicin—prostate cancer	0.000112	0.000176	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Capecitabine—prostate cancer	0.000112	0.000176	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Prednisone—prostate cancer	0.000111	0.000176	CcSEcCtD
Gamma Hydroxybutyric Acid—Anaemia—Doxorubicin—prostate cancer	0.000111	0.000175	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Prednisone—prostate cancer	0.00011	0.000174	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Epirubicin—prostate cancer	0.00011	0.000174	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Epirubicin—prostate cancer	0.00011	0.000174	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Epirubicin—prostate cancer	0.00011	0.000174	CcSEcCtD
Gamma Hydroxybutyric Acid—Agitation—Doxorubicin—prostate cancer	0.00011	0.000174	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC22A3—prostate cancer	0.00011	0.000585	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HSD3B1—prostate cancer	0.00011	0.000585	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anxiety—Epirubicin—prostate cancer	0.00011	0.000173	CcSEcCtD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000109	0.000173	CcSEcCtD
Gamma Hydroxybutyric Acid—Asthenia—Capecitabine—prostate cancer	0.000109	0.000172	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GGT1—prostate cancer	0.000108	0.000578	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dry mouth—Epirubicin—prostate cancer	0.000108	0.00017	CcSEcCtD
Gamma Hydroxybutyric Acid—Vertigo—Doxorubicin—prostate cancer	0.000107	0.00017	CcSEcCtD
Gamma Hydroxybutyric Acid—Syncope—Doxorubicin—prostate cancer	0.000107	0.00017	CcSEcCtD
Gamma Hydroxybutyric Acid—Urticaria—Prednisone—prostate cancer	0.000107	0.000169	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Docetaxel—prostate cancer	0.000107	0.000169	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NCOA1—prostate cancer	0.000107	0.000569	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Prednisone—prostate cancer	0.000107	0.000169	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Epirubicin—prostate cancer	0.000106	0.000168	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000106	0.000566	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Palpitations—Doxorubicin—prostate cancer	0.000106	0.000167	CcSEcCtD
Gamma Hydroxybutyric Acid—Oedema—Epirubicin—prostate cancer	0.000106	0.000167	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TBXAS1—prostate cancer	0.000105	0.000561	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA4—prostate cancer	0.000105	0.000561	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP19A1—prostate cancer	0.000105	0.000561	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Loss of consciousness—Doxorubicin—prostate cancer	0.000105	0.000166	CcSEcCtD
Gamma Hydroxybutyric Acid—Infection—Epirubicin—prostate cancer	0.000105	0.000166	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Epirubicin—prostate cancer	0.000104	0.000164	CcSEcCtD
Gamma Hydroxybutyric Acid—Convulsion—Doxorubicin—prostate cancer	0.000104	0.000164	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Capecitabine—prostate cancer	0.000104	0.000164	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—EP300—prostate cancer	0.000104	0.000552	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervous system disorder—Epirubicin—prostate cancer	0.000103	0.000164	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Docetaxel—prostate cancer	0.000103	0.000163	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypertension—Doxorubicin—prostate cancer	0.000103	0.000163	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA2—prostate cancer	0.000103	0.000547	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Skin disorder—Epirubicin—prostate cancer	0.000102	0.000162	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Epirubicin—prostate cancer	0.000102	0.000161	CcSEcCtD
Gamma Hydroxybutyric Acid—Chest pain—Doxorubicin—prostate cancer	0.000102	0.000161	CcSEcCtD
Gamma Hydroxybutyric Acid—Arthralgia—Doxorubicin—prostate cancer	0.000102	0.000161	CcSEcCtD
Gamma Hydroxybutyric Acid—Myalgia—Doxorubicin—prostate cancer	0.000102	0.000161	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—RXRA—prostate cancer	0.000102	0.000542	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anxiety—Doxorubicin—prostate cancer	0.000101	0.00016	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ABCG5—prostate cancer	0.000101	0.00054	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SULT1A1—prostate cancer	0.000101	0.00054	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000101	0.00016	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000101	0.000539	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—SRC—prostate cancer	0.000101	0.000537	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Anorexia—Epirubicin—prostate cancer	0.000101	0.000159	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Capecitabine—prostate cancer	0.0001	0.000158	CcSEcCtD
Gamma Hydroxybutyric Acid—Dry mouth—Doxorubicin—prostate cancer	9.96e-05	0.000157	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PLAU—prostate cancer	9.95e-05	0.00053	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Docetaxel—prostate cancer	9.95e-05	0.000157	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Prednisone—prostate cancer	9.94e-05	0.000157	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTA1—prostate cancer	9.9e-05	0.000528	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Docetaxel—prostate cancer	9.86e-05	0.000156	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Docetaxel—prostate cancer	9.85e-05	0.000156	CcSEcCtD
Gamma Hydroxybutyric Acid—Confusional state—Doxorubicin—prostate cancer	9.84e-05	0.000156	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—VEGFA—prostate cancer	9.8e-05	0.000523	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Docetaxel—prostate cancer	9.8e-05	0.000155	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NAT2—prostate cancer	9.79e-05	0.000522	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HSD3B2—prostate cancer	9.79e-05	0.000522	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTO1—prostate cancer	9.79e-05	0.000522	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—COMT—prostate cancer	9.79e-05	0.000522	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Oedema—Doxorubicin—prostate cancer	9.76e-05	0.000154	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTP1—prostate cancer	9.74e-05	0.000519	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CAV1—prostate cancer	9.72e-05	0.000518	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Infection—Doxorubicin—prostate cancer	9.7e-05	0.000153	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Neuronal System—MDM2—prostate cancer	9.68e-05	0.000516	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Prednisone—prostate cancer	9.68e-05	0.000153	CcSEcCtD
Gamma Hydroxybutyric Acid—Vomiting—Capecitabine—prostate cancer	9.63e-05	0.000152	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Epirubicin—prostate cancer	9.61e-05	0.000152	CcSEcCtD
Gamma Hydroxybutyric Acid—Shock—Doxorubicin—prostate cancer	9.61e-05	0.000152	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ITPR1—prostate cancer	9.58e-05	0.000511	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nervous system disorder—Doxorubicin—prostate cancer	9.57e-05	0.000151	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Capecitabine—prostate cancer	9.55e-05	0.000151	CcSEcCtD
Gamma Hydroxybutyric Acid—Insomnia—Epirubicin—prostate cancer	9.54e-05	0.000151	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Capecitabine—prostate cancer	9.54e-05	0.000151	CcSEcCtD
Gamma Hydroxybutyric Acid—Headache—Capecitabine—prostate cancer	9.49e-05	0.00015	CcSEcCtD
Gamma Hydroxybutyric Acid—Skin disorder—Doxorubicin—prostate cancer	9.48e-05	0.00015	CcSEcCtD
Gamma Hydroxybutyric Acid—Paraesthesia—Epirubicin—prostate cancer	9.47e-05	0.00015	CcSEcCtD
Gamma Hydroxybutyric Acid—Hyperhidrosis—Doxorubicin—prostate cancer	9.44e-05	0.000149	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspnoea—Epirubicin—prostate cancer	9.41e-05	0.000149	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PLCB2—prostate cancer	9.38e-05	0.0005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP2C18—prostate cancer	9.38e-05	0.0005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—LRP2—prostate cancer	9.38e-05	0.0005	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Somnolence—Epirubicin—prostate cancer	9.38e-05	0.000148	CcSEcCtD
Gamma Hydroxybutyric Acid—Anorexia—Doxorubicin—prostate cancer	9.31e-05	0.000147	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Docetaxel—prostate cancer	9.29e-05	0.000147	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Epirubicin—prostate cancer	9.29e-05	0.000147	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Prednisone—prostate cancer	9.23e-05	0.000146	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—P4HB—prostate cancer	9.2e-05	0.000491	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Decreased appetite—Epirubicin—prostate cancer	9.17e-05	0.000145	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Epirubicin—prostate cancer	9.11e-05	0.000144	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Epirubicin—prostate cancer	9.1e-05	0.000144	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—TYMS—prostate cancer	9.05e-05	0.000483	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Pain—Epirubicin—prostate cancer	9.02e-05	0.000143	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Epirubicin—prostate cancer	9.02e-05	0.000143	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TGFB1—prostate cancer	9e-05	0.00048	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Capecitabine—prostate cancer	9e-05	0.000142	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC22A1—prostate cancer	8.95e-05	0.000477	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—GSTM1—prostate cancer	8.95e-05	0.000477	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—PPARA—prostate cancer	8.95e-05	0.000477	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Prednisone—prostate cancer	8.92e-05	0.000141	CcSEcCtD
Gamma Hydroxybutyric Acid—Musculoskeletal discomfort—Doxorubicin—prostate cancer	8.89e-05	0.000141	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CG—prostate cancer	8.85e-05	0.000472	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Insomnia—Doxorubicin—prostate cancer	8.83e-05	0.00014	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—LPL—prostate cancer	8.79e-05	0.000468	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Paraesthesia—Doxorubicin—prostate cancer	8.77e-05	0.000139	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—EGF—prostate cancer	8.75e-05	0.000467	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SULT2A1—prostate cancer	8.72e-05	0.000465	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dyspnoea—Doxorubicin—prostate cancer	8.7e-05	0.000138	CcSEcCtD
Gamma Hydroxybutyric Acid—Feeling abnormal—Epirubicin—prostate cancer	8.69e-05	0.000137	CcSEcCtD
Gamma Hydroxybutyric Acid—Somnolence—Doxorubicin—prostate cancer	8.68e-05	0.000137	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Epirubicin—prostate cancer	8.63e-05	0.000136	CcSEcCtD
Gamma Hydroxybutyric Acid—Dyspepsia—Doxorubicin—prostate cancer	8.59e-05	0.000136	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MED12—prostate cancer	8.58e-05	0.000458	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Prednisone—prostate cancer	8.58e-05	0.000136	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GNG5—prostate cancer	8.51e-05	0.000454	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Prednisone—prostate cancer	8.51e-05	0.000134	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Prednisone—prostate cancer	8.5e-05	0.000134	CcSEcCtD
Gamma Hydroxybutyric Acid—Decreased appetite—Doxorubicin—prostate cancer	8.49e-05	0.000134	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CYP1A1—prostate cancer	8.48e-05	0.000452	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Prednisone—prostate cancer	8.45e-05	0.000134	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal disorder—Doxorubicin—prostate cancer	8.43e-05	0.000133	CcSEcCtD
Gamma Hydroxybutyric Acid—Fatigue—Doxorubicin—prostate cancer	8.42e-05	0.000133	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—ERCC2—prostate cancer	8.42e-05	0.000449	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urticaria—Epirubicin—prostate cancer	8.38e-05	0.000132	CcSEcCtD
Gamma Hydroxybutyric Acid—Constipation—Doxorubicin—prostate cancer	8.35e-05	0.000132	CcSEcCtD
Gamma Hydroxybutyric Acid—Pain—Doxorubicin—prostate cancer	8.35e-05	0.000132	CcSEcCtD
Gamma Hydroxybutyric Acid—Abdominal pain—Epirubicin—prostate cancer	8.34e-05	0.000132	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—KRAS—prostate cancer	8.33e-05	0.000444	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—CREBBP—prostate cancer	8.21e-05	0.000438	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NCOA3—prostate cancer	8.2e-05	0.000437	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IGF1—prostate cancer	8.1e-05	0.000432	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Feeling abnormal—Doxorubicin—prostate cancer	8.05e-05	0.000127	CcSEcCtD
Gamma Hydroxybutyric Acid—Nausea—Prednisone—prostate cancer	8.01e-05	0.000127	CcSEcCtD
Gamma Hydroxybutyric Acid—Gastrointestinal pain—Doxorubicin—prostate cancer	7.98e-05	0.000126	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—MTHFR—prostate cancer	7.91e-05	0.000422	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—HPGDS—prostate cancer	7.82e-05	0.000417	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CD—prostate cancer	7.78e-05	0.000415	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP2C19—prostate cancer	7.77e-05	0.000415	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Hypersensitivity—Epirubicin—prostate cancer	7.77e-05	0.000123	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PPARA—prostate cancer	7.76e-05	0.000414	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Urticaria—Doxorubicin—prostate cancer	7.76e-05	0.000123	CcSEcCtD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—PPARA—prostate cancer	7.72e-05	0.000412	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Abdominal pain—Doxorubicin—prostate cancer	7.72e-05	0.000122	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SERPINE1—prostate cancer	7.7e-05	0.00041	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—PIK3CA—prostate cancer	7.66e-05	0.000408	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTT1—prostate cancer	7.59e-05	0.000405	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ACHE—prostate cancer	7.59e-05	0.000405	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Epirubicin—prostate cancer	7.57e-05	0.00012	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP2A6—prostate cancer	7.5e-05	0.0004	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—TP53—prostate cancer	7.41e-05	0.000395	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—NOS3—prostate cancer	7.35e-05	0.000392	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—AKR1C3—prostate cancer	7.3e-05	0.000389	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CAV1—prostate cancer	7.3e-05	0.000389	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PRKACB—prostate cancer	7.26e-05	0.000387	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Diarrhoea—Epirubicin—prostate cancer	7.22e-05	0.000114	CcSEcCtD
Gamma Hydroxybutyric Acid—Hypersensitivity—Doxorubicin—prostate cancer	7.19e-05	0.000114	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP17A1—prostate cancer	7.18e-05	0.000383	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—JAK2—prostate cancer	7.14e-05	0.000381	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	7.1e-05	0.000379	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Asthenia—Doxorubicin—prostate cancer	7e-05	0.000111	CcSEcCtD
Gamma Hydroxybutyric Acid—Dizziness—Epirubicin—prostate cancer	6.98e-05	0.00011	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NCOA2—prostate cancer	6.84e-05	0.000365	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CB—prostate cancer	6.78e-05	0.000362	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Epirubicin—prostate cancer	6.71e-05	0.000106	CcSEcCtD
Gamma Hydroxybutyric Acid—Diarrhoea—Doxorubicin—prostate cancer	6.68e-05	0.000106	CcSEcCtD
Gamma Hydroxybutyric Acid—Rash—Epirubicin—prostate cancer	6.65e-05	0.000105	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Epirubicin—prostate cancer	6.65e-05	0.000105	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CG—prostate cancer	6.65e-05	0.000354	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Epirubicin—prostate cancer	6.61e-05	0.000104	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—SLC5A5—prostate cancer	6.53e-05	0.000348	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Dizziness—Doxorubicin—prostate cancer	6.46e-05	0.000102	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP2E1—prostate cancer	6.38e-05	0.00034	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NQO1—prostate cancer	6.31e-05	0.000336	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—INS—prostate cancer	6.29e-05	0.000335	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Epirubicin—prostate cancer	6.27e-05	9.9e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Hemostasis—AKT1—prostate cancer	6.25e-05	0.000334	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—IL2—prostate cancer	6.23e-05	0.000332	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TH—prostate cancer	6.21e-05	0.000331	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Vomiting—Doxorubicin—prostate cancer	6.21e-05	9.81e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—CREBBP—prostate cancer	6.16e-05	0.000329	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Rash—Doxorubicin—prostate cancer	6.16e-05	9.73e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—Dermatitis—Doxorubicin—prostate cancer	6.15e-05	9.72e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP3A4—prostate cancer	6.15e-05	0.000328	CbGpPWpGaD
Gamma Hydroxybutyric Acid—GABRB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	6.13e-05	0.000327	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Headache—Doxorubicin—prostate cancer	6.12e-05	9.66e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP1B1—prostate cancer	6.05e-05	0.000322	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GGT1—prostate cancer	5.86e-05	0.000312	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CD—prostate cancer	5.84e-05	0.000312	CbGpPWpGaD
Gamma Hydroxybutyric Acid—Nausea—Doxorubicin—prostate cancer	5.8e-05	9.16e-05	CcSEcCtD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NCOA1—prostate cancer	5.77e-05	0.000308	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP19A1—prostate cancer	5.68e-05	0.000303	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—EP300—prostate cancer	5.59e-05	0.000298	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—NOS3—prostate cancer	5.52e-05	0.000294	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—RXRA—prostate cancer	5.49e-05	0.000293	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—SRC—prostate cancer	5.44e-05	0.00029	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—VEGFA—prostate cancer	5.29e-05	0.000282	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—COMT—prostate cancer	5.28e-05	0.000282	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTP1—prostate cancer	5.26e-05	0.00028	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ITPR1—prostate cancer	5.18e-05	0.000276	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CB—prostate cancer	5.09e-05	0.000272	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTGS2—prostate cancer	5.05e-05	0.000269	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—TYMS—prostate cancer	4.89e-05	0.000261	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TGFB1—prostate cancer	4.86e-05	0.000259	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—GSTM1—prostate cancer	4.83e-05	0.000258	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—LPL—prostate cancer	4.74e-05	0.000253	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CYP1A1—prostate cancer	4.58e-05	0.000244	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—ERCC2—prostate cancer	4.54e-05	0.000242	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—KRAS—prostate cancer	4.5e-05	0.00024	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PTEN—prostate cancer	4.4e-05	0.000235	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—MTHFR—prostate cancer	4.27e-05	0.000228	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—EP300—prostate cancer	4.2e-05	0.000224	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PPARA—prostate cancer	4.19e-05	0.000223	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—PIK3CA—prostate cancer	4.13e-05	0.00022	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—TP53—prostate cancer	4e-05	0.000213	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CAV1—prostate cancer	3.94e-05	0.00021	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CG—prostate cancer	3.59e-05	0.000191	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—INS—prostate cancer	3.4e-05	0.000181	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Hemostasis—AKT1—prostate cancer	3.38e-05	0.00018	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—CREBBP—prostate cancer	3.33e-05	0.000177	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CD—prostate cancer	3.15e-05	0.000168	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—PIK3CA—prostate cancer	3.1e-05	0.000166	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—NOS3—prostate cancer	2.98e-05	0.000159	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CB—prostate cancer	2.75e-05	0.000147	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTGS2—prostate cancer	2.72e-05	0.000145	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A3—Metabolism—AKT1—prostate cancer	2.54e-05	0.000135	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PTEN—prostate cancer	2.38e-05	0.000127	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—EP300—prostate cancer	2.27e-05	0.000121	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—PIK3CA—prostate cancer	1.68e-05	8.94e-05	CbGpPWpGaD
Gamma Hydroxybutyric Acid—SLC16A1—Metabolism—AKT1—prostate cancer	1.37e-05	7.3e-05	CbGpPWpGaD
